Standard BioTools News and Activities

Standard BioTools is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Standard BioTools is a company listed under the stock ticker FLDM (US).

They are in:

• Medical Equipment50%
• Biotechnology50%

Acquisition, funding and merger involving Standard BioTools.

• Treeline Biosciences and Standard BioTools have announced they will merge  (posted on June 10 2026)..

View the org chart displaying its 15 main executives

Most searched biographies at Standard BioTools

• Michael Egholm, Chief Executive Officer and President
• Tom Carey, Chairman of the Board
• Fenel Eloi, Director

Create your alert
to follow the executive moves at Standard BioTools.

Standard BioTools has 1,244 competitors including Thermo Fisher Scientific (United States (USA)), Cytiva (United States (USA)) and Siemens Healthineers (Germany).

Popular M&A news in Medical Equipment

• CVC Capital Partners has announced the acquisition of WillowWood  (posted on June 18 2026).
• Spectrum Vascular has acquired Piccolo Medical (posted on June 17 2026).
• Medtronic has acquired Scientia Vascular (posted on June 14 2026).

Popular contacts in Medical Equipment

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio at Medtronic
• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific
• Ivan Tornos - Chairman, President and Chief Executive Officer at Zimmer Biomet

Learn more about the Medical Equipment industry

Press releases by Standard BioTools

• Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results | Standard BioTools Inc.
• Press Releases | Standard BioTools Inc.
• Standard BioTools Announces First Quarter 2022 Financial Results | Fluidigm Corporation
• Standard BioTools Announces Conference Call and Webcast of First Quarter 2022 Financial Results | Fluidigm Corporation
• Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging | Fluidigm Corporation
• Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fluidigm Corporation
• Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. | Fluidigm Corporation
• Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion | Fluidigm Corporation
• Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global | Fluidigm Corporation
• Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution | Fluidigm Corporation
• View more press releases Close

Social media about Standard BioTools

• Standard BioTools on Wikipedia, Google News & Yahoo Finance
• Standard BioTools on LinkedIn, X (Twitter) & YouTube